Huntington's Disease Related Antibodies
Huntington's disease (HD), also known as "chorea", was originally reported by Waters in 1842 and termed after its systematic description by American physician George Huntington in 1872. HD is a progressive disease, and patients in the early stages of HD may suffer minor involuntary movements, mild executive function impairments, and sad mood. As the disease progresses, clinical symptoms of patients typically include involuntary convulsive movements, difficulties coordinating voluntary movements, mood swings, cognitive impairment, and other mental illnesses.
Key Factors of HD
HD is an autosomal dominant disorder caused by aberrant expansion (40 or more) of DNA repeats (composed of cytosine-adenine-guanine (CAG)) toward one end of the huntingtin protein (HTT). HTT is found throughout the central nervous system and has been linked to a number of cellular activities such as protein trafficking, vesicle transport, and selective autophagy. As the number of CAG repeats rises, HTT becomes more prone to misfolding and the production of insoluble aggregates. These aggregates build up and promote cell degeneration, eventually resulting in significant shrinkage of the affected brain areas.
The pathogenic hallmarks of HD are striatal atrophy and cerebral cortex cellular degeneration. The exact function of mutant huntingtin protein (mHTT) in the pathophysiology of HD is still unknown, but research has shown that it affects HD patients in a number of ways, including autophagy dysregulation, dopaminergic imbalance, oxidative stress and mitochondrial dysfunction, unusual protein aggregation, disruption of gene transcription, loss of nutritional support, and neuroinflammation.
Fig.1
Pathogenesis of Huntington's disease.1
Important Targets Related to HD
Antibodies, as a dependable tool, are significant in HD research. Creative Biolabs has professional neuroscience and antibody R&D teams that can provide thorough and professional antibody suggestions for your HD research.
Cat. No | Product Name | Host | Application |
---|---|---|---|
NAB2105185SL | Mouse Anti-Human CREBBP Monoclonal Antibody (CBP5695) | Monoclonal | DB; ICC; IP; WB |
NAB2105186SL | NeuroMab™ Mouse Anti-CREBBP (CBP5696) | Monoclonal | IF; IHC |
NAB2105187SL | NeuroMab™ Mouse Anti-Human CREBBP (CBP5697) | Monoclonal | ELISA; IF; WB |
NAB2105189SL | Mouse Anti-Human CREBBP Monoclonal Antibody (CBP5698) | Monoclonal | ICC; IP; WB |
NRP-0322-P1903 | Anti-CREBBP Monoclonal Antibody (CBP8020) | Monoclonal | WB; IHC; ICC; IP |
Cat. No | Product Name | Host | Application |
---|---|---|---|
NAB2007FY665 | Mouse Anti-VDAC1 Monoclonal Antibody (CBP2022) | Monoclonal | WB; IHC; ICC; IF |
NAB2010354LS | NeuroMab™ Mouse Anti-VDAC1 Monoclonal Antibody (CBP2356) | Monoclonal | WB; IHC-P |
NRP-0422-P458 | NeuroMab™ Anti-VDAC1, Clone N152B/23 (CBP8559) | Monoclonal | WB; IHC; ICC |
NRZP-0922-ZP4706 | NeuroMab™ Anti-VDAC Antibody, Clone N29361 (CBP16017) | Monoclonal | WB; IHC |
NRZP-0423-ZP458 | NeuroMab™ Anti-VDAC1 BBB Shuttle Antibody, Clone N152B/23 | Monoclonal | WB; IHC; ICC |
Cat. No | Product Name | Host | Application |
---|---|---|---|
NAB-08-PZ1113 | Rabbit Anti-Human REST Monoclonal Antibody (CBP1679) | Monoclonal | IHC-P; ICC; IF |
NAB2007FY1703 | Mouse Anti-REST Monoclonal Antibody (CBP6754) | Monoclonal | IHC; IF |
Cat. No | Product Name | Host | Application |
---|---|---|---|
NAB20101997CR | Mouse Anti-HIP1 Monoclonal Antibody (CBP2919) | Monoclonal | IHC; WB; ELISA |
NAB-0720-Z6078 | NeuroMab™ Rabbit Anti-HIP1 Monoclonal Antibody (CBP3246) | Monoclonal | ICC; IF; WB; IP |
NAB-2103-P365 | NeuroMab™ Mouse Anti-HIP1 Monoclonal Antibody (CBP4770) | Monoclonal | WB; IP; IF; IHC-P |
NAB-2103-P370 | NeuroMab™ Mouse Anti-HIP12 Monoclonal Antibody (CBP4775) | Monoclonal | WB; IP |
NAB-0421-R0639 | NeuroMab™ Mouse Anti-HIP7 Monoclonal Antibody (CBP6056) | Monoclonal | IHC; WB |
You may contact us directly or use the related products below to request additional information, and we will respond as soon as we can.
Reference
- Jiang, Andrew, et al. "From pathogenesis to therapeutics: a review of 150 years of Huntington’s disease research." International journal of molecular sciences 24.16 (2023): 13021. Distributed under Open Access license CC BY 4.0, without modification.
- Mouse Anti-SCN5A Monoclonal Antibody (CBP708) (Cat#: NAB-0720-Z2720)
- iNeuMab™ Rabbit Anti-LRRK2 Monoclonal Antibody (CBP1887) (Cat#: NAB-08-PZ735)
- iNeuMab™ Mouse Anti-SHANK3 Monoclonal Antibody (CBP929) (Cat#: NAB-0720-Z3477)
- iNeuMab™ Anti-F-Spondin/SPON1 Antibody, Clone 3F4 (Cat#: NRZP-0822-ZP4740)
- Mouse Anti-Human α-Synuclein Phospho (Tyr39) (CBP3706) (Cat#: NAB201250LS)
- iNeuMab™ Rabbit Anti-Alpha-synuclein (CBP1631) (Cat#: NAB-08-PZ079)
- iNeuMab™ Mouse Anti-LRP1 Monoclonal Antibody (CBP3363) (Cat#: NAB-0720-Z6479)
- iNeuMab™ Mouse Anti-EFNB2 Monoclonal Antibody (CBP1159) (Cat#: NAB-0720-Z4396)
- Human Astrocytes, Immortalized (Cat#: NCL-2105-P182-AM)
- iNeu™ Human Oligodendrocyte Progenitor Cells (OPCs) (Cat#: NCL-2103-P49)
- iNeu™ Human Neural Stem Cell Line (Cat#: NCL200552ZP)
- Rat Microglia Cell Line HAPI, Immortalized (Cat#: NCL2110P015)
- iNeu™ Human Motor Neurons (Cat#: NCL-2103-P71)
- Human Brain Astroblastoma U-87 MG (Cat#: NCL2110P117)
- iNeu™ Human Schwann Cell (Cat#: NCL-2103-P63)
- Mouse Glioma Cell Line GL261-GFP (Cat#: NCL-2108P04)
- Human Glial (Oligodendrocytic) Hybrid Cell Line (MO3.13) (Cat#: NCL-2108P34)
- Mouse Microglia from C57BL/6 (Cat#: NCL-21P6-082)
- Human Poly ADP ribose polymerase,PARP Assay Kit (Cat#: NRZP-1122-ZP62)
- Alpha Synuclein Aggregation Kit (Cat#: NRZP-1122-ZP15)
- Amyloid beta 1-42 Kit (Cat#: NRP-0322-P2170)
- Human Tau Aggregation Kit (Cat#: NRP-0322-P2173)
- Beta Amyloid (1-42), Aggregation Kit (Cat#: NRZP-0323-ZP200)
- Beta Amyloid (1-40), Aggregation Kit (Cat#: NRZP-0323-ZP199)
- Alpha-Synuclein Aggregation Assay Kit (Cat#: NRZP-1122-ZP37)
- Human GFAP ELISA Kit [Colorimetric] (Cat#: NPP2011ZP383)
- VSV-eGFP (Cat#: NTA-2011-ZP20)
- AAV2 Full Capsids, Reference Standards (Cat#: NTC2101070CR)
- Dextran, NHS Activated (Cat#: NRZP-0722-ZP124)
- Mouse Parkinson disease (autosomal recessive, early onset) 7 (Park7) (NM_020569) clone, Untagged (Cat#: NEP-0621-R0133)
- Rat Parkinson disease (autosomal recessive, juvenile) 2, parkin (Park2) (NM_020093) ORF clone/lentiviral particle, Myc-DDK Tagged (Cat#: NEP-0621-R0041)
- Human huntingtin (HTT) (NM_002111) ORF clone, Myc-DDK Tagged (Cat#: NEP-0521-R0497)
- Human apolipoprotein E (APOE) (NM_000041) ORF clone, Untagged (Cat#: NEP-0421-R0232)
- Lenti of Mouse synuclein, alpha (Snca) transcript variant (NM_001042451) ORF clone, mGFP Tagged (Cat#: NEP-0521-R0864)
- App Rat amyloid beta (A4) precursor protein (App)(NM_019288) ORF clone, Untagged (Cat#: NEP-0421-R0053)
- ABCA1 Antisense Oligonucleotide (NV-2106-P27) (Cat#: NV-2106-P27)
- Human superoxide dismutase 3, extracellular (SOD3) (NM_003102) ORF clone, Untagged (Cat#: NEP-0521-R0808)
- Tau Antisense Oligonucleotide (IONIS-MAPTRx) (Cat#: NV-2106-P29)
- Mouse SOD1 shRNA Silencing Adenovirus (Cat#: NV-2106-P14)
- NeuroBiologics™ Mouse Cerebrospinal Fluid (Cat#: NRZP-0822-ZP497)
- NeuroBiologics™ Monkey Cerebrospinal Fluid (Cat#: NRZP-0822-ZP495)
- NeuroBiologics™ Rat Cerebrospinal Fluid (Cat#: NRZP-0822-ZP496)
- NeuroBiologics™ Pig Cerebrospinal Fluid (Cat#: NRZP-0822-ZP498)
- NeuroBiologics™ Human Cerebrospinal Fluid (Cat#: NRZP-0822-ZP491)
- NeuroPro™ Anti-ASA BBB Shuttle Protein (Cat#: NRZP-0423-ZP504)
- NeuroPro™ Anti-TNFR BBB Shuttle Protein (Cat#: NRZP-0423-ZP501)
- NeuroPro™ Anti-GDNF BBB Shuttle Protein (Cat#: NRZP-0423-ZP509)
- NeuroPro™ Anti-IDUA BBB Shuttle Protein (Cat#: NRZP-0423-ZP498)
- NeuroPro™ Anti-IDS BBB Shuttle Protein (Cat#: NRZP-0423-ZP503)
- NeuroPro™ Anti-Erythropoietin BBB Shuttle Protein (Cat#: NRZP-0423-ZP499)
- NeuroPro™ Anti-SGSH BBB Shuttle Protein (Cat#: NRZP-0423-ZP505)
- NeuroPro™ Anti-PON1 BBB Shuttle Protein (Cat#: NRZP-0423-ZP507)
- NeuroPro™ Anti-IDUA BBB Shuttle Protein (Cat#: NRZP-0423-ZP502)
- NeuroPro™ Anti-NAGLU BBB Shuttle Protein (Cat#: NRZP-0423-ZP506)